Latest stories on GTBP
GT Biopharma, Inc. (GTBP) files 8-K: Items 5.07, 9.01
SEC 8-K50 · neutralgeneral
GT Biopharma Oral Presentation at the SITC 2026 Annual Meeting
GlobeNewswire58 · neutralproduct/pr
GT Biopharma Oral Presentation at the SITC 2026 Annual Meeting
Business Insider58 · neutralproduct/pr
GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting
GlobeNewswire56 · neutralproduct/pr
GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting
Business Insider56 · neutralproduct/pr
GT Biopharma, Inc. (GTBP) files 8-K
SEC 8-K50 · neutralgeneral
GT Biopharma, Inc. (GTBP) files 8-K
SEC 8-K50 · neutralgeneral
GT Biopharma trading halted, volatility trading pause
The Fly42 · neutralgeneral
GT Biopharma trading resumes
The Fly50 · neutralgeneral
GT Biopharma announces IND clearance from FDA for GTB-5550 in multiple myeloma
The Fly63 · neutralgeneral
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
Business Insider67 · bullishproduct/pr
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
GlobeNewswire67 · bullishproduct/pr
GT Biopharma, Inc. (GTBP) files 8-K
SEC 8-K50 · neutralgeneral
GT Biopharma, Inc. (GTBP) Discusses TriKE Platform, Clinical Progress, and the Case for NK Cell Immunotherapy Transcript
Seeking Alpha56 · neutralproduct/pr
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
GlobeNewswire56 · neutralproduct/pr
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
Business Insider56 · neutralproduct/pr
GT Biopharma trading halted, news pending
The Fly48 · neutralgeneral
GT Biopharma Implements Reverse Stock Split, Streamlines Capital Structure
TipRanks34 · bearishgeneral
GT Biopharma, Inc. (GTBP) files 8-K
SEC 8-K50 · neutralgeneral
GT Biopharma, Inc. (GTBP) files 8-K
SEC 8-K50 · neutralgeneral
GT Biopharma reports Q2 results
Seeking Alpha34 · bearishearnings
GT Biopharma Reports Second Quarter 2026 Financial Results
GlobeNewswire50 · neutralgeneral
GT Biopharma Reports Second Quarter 2026 Financial Results
Business Insider55 · neutralgeneral
A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs
PR Newswire63 · neutralproduct/pr
A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs
PR Newswire63 · neutralproduct/pr